Trial Archives: Completed

---

Protocol EMR 62-225, Merck, Parkinson’s Disease

- March 24, 2011

Protocol 609-04, Medivir AB, Herpes Simples Labialis

- March 24, 2011

Protocol MP-1501-02, Medicus Pharmaceuticals, Acne Vulgaris

- March 24, 2011

Protocol 04-001, Jazz Pharmaceuticals, Adult Generalized Anxiety Disorder

- March 24, 2011

Protocol 04-003 Open Label, Jazz Pharmaceuticals, Adult Generalized Anxiety Disorder

- March 24, 2011

Protocol 331333-PAI-3015, J & J, Diabetic Peripheral Neuropathy

- March 24, 2011

Protocol 39039039-AFL-3001, J & J, Non-Valvular Atrial Fibrillation

- March 24, 2011

Protocol IPX056-B06-03, Impax Labs, Multiple Sclerosis Spasticity

- March 24, 2011

Protocol TRX105852, GSK, Menstrual Migraines

- March 24, 2011

Protocol TRX103635, GSK, Multiple Migraines

- March 24, 2011

Protocol 101468228, GSK, Parkinson’s Disease

- March 24, 2011

Protocol 1000368, GSK, Major Depression Disorder

- March 24, 2011

Protocol 101998, GSK, Migraine

- March 24, 2011

Protocol SCT-MD-39, Forest Labs, Depression

- March 24, 2011

Protocol SCT-MD-35, Forest Labs, Adult Depression

- March 24, 2011